Navigation Links
George Golumbeski, President of GRAIL, Inc. to Deliver Keynote at BD Boston 2018
Date:7/26/2018

Boston Biotech Conferences will host BD Boston, an invitation-only, off-the-record meeting for C-level biopharma executives on September 4, 2018 at The Hilton Boston Back Bay Hotel. This peer-to-peer meeting provides an opportunity for industry leaders to leverage insight from real-life business development experiences and dissect the most relevant deals in biotech.

George Golumbeski recently joined GRAIL with more than 25 years of experience in the biotechnology industry. He currently serves on the Board of Directors at KSQ Therapeutics, Carrick Therapeutics, Enanta Pharmaceuticals, and MorphoSys. Dr. Golumbeski was most recently Executive Vice President of Business Development for Celgene, where he was responsible for forging collaborations with biotechnology companies seeking to bring breakthrough medications to people suffering from cancer and chronic inflammation.

To attend, please register here.

ABOUT BOSTON BIOTECH CONFERENCES:
Boston Biotech Conferences are exclusive, thought-leader forums for senior biopharma executives. Each conference is highly interactive and co-hosted by healthcare industry leaders to foster discussions and facilitate information-sharing, networking and corporate development within the biopharma community. These meetings convene the most relevant players in biotech to network, forge partnerships and leverage the experiences of their peers in an off-the-record setting. For more information, please visit: http://www.bostonbiotechconferences.com

Contact:
Boston Biotech Conferences
Suzanne Carroll: suzanne@bbbiotechconference.com
Nicole Hayes: nicole@bbbiotechconference.com

Read the full story at https://www.prweb.com/releases/george_golumbeski_president_of_grail_inc_to_deliver_keynote_at_bd_boston_2018/prweb15648780.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. The American Society for Microbiology honors George L. Drusano
2. Stephen Zarrilli Named President & CEO of University City Science Center
3. How to Fix President Trumps "Travel Ban" Executive Order; a 9/11 Commission Counsels Perspective
4. Texas Biomed Names Larry Schlesinger, M.D. As President/CEO
5. Genpact Executive Jeff Schultz Joins QStride As Vice President of National Business Development
6. Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer
7. American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect
8. EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables
9. Colombian president honors WCS president and CEO Dr. Cristián Samper
10. NXT-ID, Inc. Names Vice-President and Chief Financial Officer
11. JAX President and CEO Edison Liu, M.D., to receive Chen Award from HUGO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2019)... Colo. (PRWEB) , ... July 18, 2019 , ... ... announced the addition of Meredith James, HT, PMP, to its executive team as ... over 20 years in drug development. In her new role, Ms. James is ...
(Date:7/17/2019)... ... July 17, 2019 , ... ... in the Southeast, and its acclaimed pediatric urologists are among the professionals ... This annual recognition signifies excellence among the country’s pediatric healthcare landscape. , ...
(Date:7/17/2019)... ... 15, 2019 , ... RCH Solutions (RCH), a ... companies, announces the availability of new specialty advisory practice, a Public Cloud Managed ... emerging bio-pharma companies interested in achieving specific outcomes related to public Cloud adoption. ...
Breaking Biology News(10 mins):
(Date:7/9/2019)... , ... July 08, 2019 , ... ... The company’s SmartLight Indicator was recognized as the 2019 Innovative Product of the ... forward. The prestigious awards were during Sensors Expo & Conference 2019, ...
(Date:6/26/2019)... ... 26, 2019 , ... Alice Branton today released research results from preclinical trials ... Gluconate, which can prove to be beneficial for treating Hypomagnesemia. , The preclinical trial ... in crystallite size , Over 142% increase in particle size , ...
(Date:6/18/2019)... ... June 18, 2019 , ... Personalized Stem Cells, Inc ... (IND) application to the FDA for use of a person’s own adipose-derived stem cells ... of osteoarthritis in the knee. This IND is the first of several planned ...
(Date:6/11/2019)... ... June 10, 2019 , ... ... distribution network with the appointment of Biofeedback Tech Ltd as its ... are an essential part of many therapeutic treatments and clinical assessment protocols to ...
Breaking Biology Technology: